Bicocca Open Archive

Logo unimib boa
PAGAN, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.078
AS - Asia 5.002
EU - Europa 3.457
SA - Sud America 674
Continente sconosciuto - Info sul continente non disponibili 441
AF - Africa 111
OC - Oceania 18
Totale 16.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.656
SG - Singapore 1.572
IT - Italia 1.318
VN - Vietnam 1.168
CN - Cina 741
DE - Germania 646
HK - Hong Kong 636
BR - Brasile 505
RU - Federazione Russa 428
CA - Canada 305
SE - Svezia 254
BD - Bangladesh 214
IE - Irlanda 179
FR - Francia 167
IN - India 148
GB - Regno Unito 118
ID - Indonesia 106
KR - Corea 71
AR - Argentina 68
FI - Finlandia 58
JP - Giappone 46
TR - Turchia 44
NL - Olanda 43
UA - Ucraina 40
PK - Pakistan 38
IQ - Iraq 34
ZA - Sudafrica 33
ES - Italia 32
AT - Austria 30
MX - Messico 28
EC - Ecuador 27
PH - Filippine 25
PL - Polonia 25
CH - Svizzera 24
SA - Arabia Saudita 24
DK - Danimarca 23
CO - Colombia 22
IR - Iran 17
JM - Giamaica 16
AU - Australia 15
CR - Costa Rica 15
MY - Malesia 14
PY - Paraguay 14
TN - Tunisia 14
ET - Etiopia 12
IL - Israele 11
RO - Romania 11
KE - Kenya 10
PR - Porto Rico 10
TH - Thailandia 10
UZ - Uzbekistan 10
CL - Cile 9
EG - Egitto 9
HN - Honduras 9
LB - Libano 9
PE - Perù 9
TW - Taiwan 9
VE - Venezuela 9
BG - Bulgaria 8
CZ - Repubblica Ceca 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
GR - Grecia 7
MA - Marocco 7
NI - Nicaragua 7
SV - El Salvador 7
EE - Estonia 6
JO - Giordania 6
KG - Kirghizistan 6
KZ - Kazakistan 6
BE - Belgio 5
CW - ???statistics.table.value.countryCode.CW??? 5
DZ - Algeria 5
GT - Guatemala 5
PS - Palestinian Territory 5
SN - Senegal 5
TT - Trinidad e Tobago 5
HU - Ungheria 4
UY - Uruguay 4
GE - Georgia 3
GP - Guadalupe 3
HR - Croazia 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GH - Ghana 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
PA - Panama 2
Totale 16.319
Salva come PNG Salva come JPEG
Città #
Ann Arbor 819
Singapore 807
Ashburn 759
Hong Kong 614
Frankfurt am Main 532
San Jose 453
Milan 369
Ho Chi Minh City 339
Fairfield 261
Hanoi 252
Wilmington 213
Toronto 208
Council Bluffs 191
Santa Clara 188
Dallas 174
Dublin 168
New York 155
Houston 151
Chicago 135
Hefei 126
Los Angeles 124
Chandler 117
Rome 116
Seattle 111
Beijing 101
The Dalles 96
Woodbridge 94
Princeton 92
Jakarta 86
Cambridge 78
Lauterbourg 61
Moscow 57
Dearborn 54
Dong Ket 49
Seoul 49
Columbus 46
Altamura 45
Lawrence 44
Shanghai 44
San Diego 42
Buffalo 38
Helsinki 38
Phoenix 36
Da Nang 35
Guangzhou 35
North Bergen 35
Nanjing 32
Atlanta 31
Haiphong 31
São Paulo 31
Biên Hòa 30
Boardman 30
Ha Long 27
Munich 27
Naples 27
Tokyo 27
Montreal 26
Turin 25
Nuremberg 24
Elk Grove Village 23
Jacksonville 22
Sacramento 22
Brooklyn 21
Warsaw 21
London 19
Figino 18
Hải Dương 18
Thái Nguyên 18
Zurich 17
Ardea 16
Mumbai 16
Quận Bình Thạnh 16
Bologna 15
Denver 15
Dhaka 15
Monza 15
Orem 15
Brasília 14
Miami 14
Salt Lake City 14
Andover 13
Brescia 13
Chennai 13
Kent 13
Quận Một 13
Vienna 13
Johannesburg 12
Lappeenranta 12
Philadelphia 12
Rio de Janeiro 12
Seregno 12
Umeå 12
Washington 12
Baghdad 11
Carate Brianza 11
Charlotte 11
Hangzhou 11
Las Vegas 11
Paris 11
San José 11
Totale 9.608
Salva come PNG Salva come JPEG
Nome #
Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies 660
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 541
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes 423
Laryngeal cancer mortality trends in European countries 416
Male breast cancer: a multicenter study to provide a guide for proper management 395
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study 389
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis 345
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 336
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer." 302
Sex-based differences of the Tumor mutational burden and T-cell inflammation of the tumor microenvironment 302
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ 298
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 296
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 293
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers 292
Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study 286
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 283
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer 269
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates 268
Sex-based differences in cancer immunotherapy efficacy 261
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 256
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 253
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 252
Endocrine-responsive lobular carcinoma of the breast: Features associated with risk of late distant recurrence 248
Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports 244
Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients 244
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland 240
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 237
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial 234
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 229
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 229
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 228
Association of prebiotic fiber intake with colorectal cancer risk: the PrebiotiCa study 227
Comparative Efficacy of Classic Versus Horizontal Incision Techniques in Skin-Reducing Mastectomy: A Single Center Retrospective Analysis 226
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 224
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” 219
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up 218
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 215
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 212
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study 210
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer 209
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 205
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 202
Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media 201
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 195
Different Response to Immunotherapy According to Melanoma Histologic Subtype 195
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer? 189
How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes 183
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 181
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 175
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? 173
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 170
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 167
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer: A feasibility phase II trial 167
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas 166
Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation 166
Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer 157
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 152
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center 148
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 147
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials 147
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis 144
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment - Authors' reply 144
Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants 143
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 142
One-Year Mortality in Hospitalized, Frail Older Adults with Atrial Fibrillation on Oral Anticoagulant Therapy: Impact of Stroke and Bleeding Events 141
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 138
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer: A Cohort Study 137
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 134
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment 132
Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013 124
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials 123
Effect of a Multimedia-Assisted Informed Consent Procedure on the Information Gain of Patients Undergoing Mastectomy and Implant-Based Reconstruction 113
Effects of multidomain interventions on health outcomes in older adults: A systematic review and meta-analysis 87
Pragmatic cluster-randomised trial of a multidomain intervention to prevent hospital-acquired disability: the OPTIMAge-IT study protocol 84
Totale 16.781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022546 0 0 0 33 24 72 33 45 46 79 70 144
2022/20231.251 149 352 172 105 102 185 29 34 24 34 32 33
2023/2024776 18 15 29 72 79 158 106 46 72 40 31 110
2024/20252.649 129 306 135 132 159 138 164 93 296 329 307 461
2025/20266.723 846 772 520 575 544 261 818 325 437 521 511 593
2026/20272.508 280 353 759 1.116 0 0 0 0 0 0 0 0
Totale 16.781